Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Related Enduring Materials

Enduring Materials

Day 1 - Thursday, 17 September 2020

Opening session - 14:00
14:00 CEST
Opening of the Workshop
Session 1: What is New in HIV Prevention and Epidemiology? - 14:05
14:05 CEST
2020: Have We Reached the 90-90-90 Targets?
Teymur Noori, MSc
European Centre for Disease Prevention and Control (ECDC), Sweden
14:20 CEST
PrEP Implementation in the CEE Region: What are the Successes, What are the Barriers?
Miłosz Parczewski, MD, PhD
Pomeranian Medical University, Szczecin, Poland
14:35 CEST
Harm Reduction Strategies in Drug Users: What Can We Learn?
Tetiana Deshko, MBA, PhD
Alliance for Public Health, Ukraine
Session 2: HIV and Viral Hepatitis in Women: Hot Topics - 15:15
15:15 CEST
ART in Women: Which Drugs are Safe and What are the Challenges?
Anette Haberl
Annette Haberl, MD
HIVCENTER University Hospital Frankfurt, Germany
15:30 CEST
Management of Viral Hepatitis during Pregnancy
Yvonne Gilleece, MB, BCh, BAO
Brighton & Sussex Medical School and University Hospitals Sussex NHS Foundation Trust, United Kingdom
Industry-sponsored Symposium - 16:00
16:00 CEST
Industry-sponsored Symposium
Session 3: Abstract - driven presentations - 16:55
16:55 CEST
Characteristics of women diagnosed with HIV in the WHO European Region and predictors of late diagnosis
Otilia Mårdh
ECDC, Sweden
17:00 CEST
A pilot study of the acceptability and feasibility of HCV self-testing among key populations in Georgia
Sonjelle Shilton
FIND, Switzerland
17:05 CEST
Evidence of experience in Community-based HCV Treatment among HIV/HCV Co-infected PWIDs in Ukraine
Zahedul Islam
Alliance Public Health, Ukraine
17:10 CEST
Determination of drug resistance of hepatitis C virus to NS5A protein inhibitors as a new approach to personalized medicine
Elena Gasich
The Republican Research And Practical Center For Epidemiology And Microbiology (rrpcem), Belarus
Session 4: Debate: Do Integrase Inhibitors and/or TAF Lead to Weight Gain? - 17:25
17:25 CEST
Con Standpoint
Jürgen Rockstroh, MD
University of Bonn, Germany
17:35 CEST
Pro Standpoint
Laura Waters, MD, FRCP
Central & North West London NHS Foundation Trust, United Kingdom

Day 2 - Friday, 18 September 2020

Introduction Day 2 - 14:00
14:00 CEST
Introduction Day 2
Session 5: What is New in the Antiretroviral Treatment Armamentarium? - 14:05
14:05 CEST
Managing Highly Treatment-Experienced Patients: What are the New Drug Options?
Anca Streinu-Cercel, MD, PhD
National Institute of Infectious Diseases "Prof. Dr. Matei Bals", Romania
14:20 CEST
Long-Acting Therapies: Which Patients Will Benefit Most?
Sharon Walmsley, CM, MD, FRCPC
University Health Network, Canada
Industry-Sponsored Symposium - 14:55
14:55 CEST
Industry-Sponsored Symposium
Session 6: Abstract-driven Presentations - 15:55
15:55 CEST
Quality of lives of PLWHA from Baylor Clinic in Constanta, Romania decreased during the COVID-19 pandemic
Ana-Maria Schweitzer
Baylor Black Sea Foundation, Romania
16:00 CEST
Coinfection with hepatitis viruses in patients with HIV infection
Oana Sandulescu
Carol Davila University of Medicine and Pharmacy, Romania
16:05 CEST
Development of structural changes in patients treated for VHC in the Czech Republic from viewpoint of stage of liver fibrosis, HCV genotype, age and treatment strategy
Viktor Aster
Charles University, Bulovka Hospital, Czech Republic
Session 7: Hot Topics in HIV and Hepatitis - 16:25
16:25 CEST
STI Diagnostics in the CEE Region
Pawel Jakubowski, MD, MBA
Szpitale Pomorskie (Pomeranian Hospitals), Poland
16:40 CEST
The Acute HCV Epidemic in MSM: What Have We Learned Thus Far?
Christoph Boesecke, MD
Universitätsklinikum Bonn, Germany
16:55 CEST
HIV and COVID-19 co-infection: An Update
Cristiana Oprea, MD, PhD
“Carol Davila” University of Medicine and Pharmacy, Romania
Overview
Welcome

The sixth edition of the Central and Eastern European Meeting on Viral Hepatitis and HIV was held as a virtual conference on 17- 18 September 2020. 

The Central and Eastern European Meeting on Viral Hepatitis and HIV is an independent program, initiated in 2014 and developed by regional and international key opinion leaders for the medical and scientific community in Eastern and Central European countries. Advances in the treatment of viral hepatitis and HIV are continuing at a rapid and exciting pace and are presented and discussed at many large international conferences. Key challenges in the treatment of hepatitis B and C as well as HIV are specific for this region and need to be discussed among clinicians and scientists from these countries.

Program Chairs 2020

General Information 

COVID-19 Update
In light of the COVID-19 pandemic, the CEE Meeting on Viral Hepatitis and HIV 2020 was held as a completely virtual meeting. In this way, the program was delivered safely and conveniently. Ample time was reserved for discussion and virtual networking opportunities.
Meeting Objectives
This meeting aims to:

• Educate the practicing clinician on the best treatment options for viral hepatitis and co-infection with HIV

• Share state-of-the-art information and how it relates to daily clinical practice

• Provide a Central and Eastern European platform for interaction and dialogue

• Stimulate discussion among different disciplines

• Build collaborations and developing research activities
Learning Objectives
After participating in this activity, participants will be able to:

• Summarize the basic concepts of viral hepatitis and HIV

• Describe the spread of viral hepatitis and HIV in Central and Eastern Europe

• Be updated on the latest developments in treatment strategies for hepatitis mono- and HIV co-infected patients

• Summarize the specific treatment challenges in Central and Eastern Europe

• Identify and adjust treatment strategies in different patient populations

• Discuss the advantages and possibilities of new antivirals in HBV, HCV, and
HIV therapy

Practical Information 

Certificate of Attendance
A certificate of attendance was sent to participants that successfully completed the meeting and post-meeting survey.
Language
The official language of the meeting was English.
Translation was not provided.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official conference sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the conference is finished, provided the speaker has given permission to do so.
Committees
Chairs 2020
Organizing Committee
Cihan Yurdaydin
Cihan Yurdaydin, MD
Department of Gastroenterology and Hepatology, University Medical School, Istanbul, Turkey

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

Scientific Committee

The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

  • Viktor Aster, MD, PhD - Charles University, Czech Republic
  • Inga Ažiņa, MD, PhD - Rīga Stradiņš University, Latvia
  • Marine Gogia, MD - Georgian Harm Reduction Network, Georgia
  • Andrzej Horban, MD, PhD - Hospital for Infectious Diseases, Poland
  • David Jilich, MD - HIV Centre Prague, Czech Republic
  • Natalia Matsieuskaya, MD, PhD - Grodno State Medical University, Belarus
  • Cristina Popescu, MD, PhD - Carol Davila University of Medicine and Pharmacy, Romania
  • Baiba Rozentāle, MD, PhD, MBA - Rīga Stradiņš University, Latvia
  • Kristi Rüütel, MD, PhD - Scientific Institute for Health Development, Estonia
  • Dalibor Sedláček, MD, PhD - University Hospital Plzen, Czech Republi
  • Ligita Jančorienė, MD, PhD - Vilnius University Hospital Santaros Klinikos, Lithuania
  • Tetyana Kyrychenko, MD, PhD - Poltava Regional HIV/AIDS Prevention And Control Center, Ukraine
Support
Endorsers
Language